Breast cancer is now the most commonly diagnosed cancer in Australia. Although it has one of the highest survival rates, thanks largely to research, 10 per cent of those diagnosed with breast cancer still die from the disease within five years.
To inform research investment and more effectively work towards the goal of zero deaths by 2030, the National Breast Cancer Foundation (NBCF) has commissioned an Australian-first research project to understand who is most at risk of dying from breast cancer.
NBCF has invited Professor David Roder, Chair of Cancer Epidemiology and Population Health at the University of Adelaide to undertake a project that will provide valuable information on pockets of risk among the population.
This information will bring together information on breast cancer care and outcomes which currently sits in many different places. Bringing it all together will allow for a substantial leap forward in understanding which women have worse health outcomes compared to others, the detailed reasons for the disparity and its consequences.
NBCF will use the information to make data-driven decisions in setting research priority areas for breast cancer research funding. It will also provide a platform for NBCF to advocate changes in public health policy and service delivery that could help close the gap.
Professor David Roder looks into breast cancer data
Professor Roder is particularly well positioned to lead this Australian-first project due to his specific expertise in epidemiology and population health, as well as his ability to access various sources of e-health data.
“This research aims to increase patient survival and improve care more generally for the many thousands of Australians affected by cancer each year and this project will be an important tool to help us achieve that.”
“Through this partnership with NBCF, we hope to speed up the translation of research evidence into health practice to save and improve the lives of breast cancer patients in Australia,” said Professor Roder.
Professor Roder has a wide range of experience in cancer population health and has provided expert consultation to the Australian government and health institutes and organisations across the country.